सभी अध्ययन
सक्रिय लेकिन भर्ती नहींचरण3हस्तक्षेपात्मक

Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis

This study, called RAISE-XT, is for existing participants in a trial looking at a medicine called zilucoplan. It focuses on people living with a muscle weakness condition known as generalized myasthenia gravis (gMG). The main goal is to understand how well zilucoplan works and how safe it is over a longer period. By continuing to follow people who have already taken the medicine, researchers can gather important information about its long-term effects. This helps us learn more about zilucoplan as a treatment option for gMG, hoping to improve care for those with the condition. It’s an extension of previous studies, meaning it continues to observe people who have already started the treatment.

एक नजर में

स्थिति
सक्रिय लेकिन भर्ती नहीं
चरण
चरण3
प्रायोजक
UCB Biopharma SRL
नामांकन लक्ष्य
200
प्रारंभ
23 Dec 2019
अनुमानित पूर्णता
27 Jul 2026

यह अध्ययन किस बारे में है?

This study, known as RAISE-XT, is designed for people who have generalized myasthenia gravis (gMG) and have already taken part in a previous study testing a medicine called zilucoplan. Generalized myasthenia gravis is a condition that causes muscle weakness in different parts of the body, which can make everyday tasks difficult. Zilucoplan is a new treatment being investigated for this condition. The earlier studies looked at how zilucoplan worked over a shorter period.

This new study is an 'open-label extension', which means that participants and the study team will know that everyone involved is receiving zilucoplan. It's about seeing how the medicine works and if it's safe when used for a longer time. By continuing to gather information from people who have already tried zilucoplan, researchers hope to get a clearer picture of its long-term benefits and any side effects.

The main aim is to understand if zilucoplan can help manage gMG symptoms effectively over many months or even years, and if it continues to be a safe treatment option. This kind of long-term study is very important because it helps doctors and patients make informed decisions about treatments for chronic conditions like gMG, ultimately aiming to improve quality of life.

मुख्य निष्कर्ष

  • This study is for long-term follow-up of zilucoplan.
  • It's for people with generalized myasthenia gravis.
  • You must have been in a previous zilucoplan study.
  • The goal is to check long-term safety and how well it works.
  • You'll be closely monitored by doctors.
  • आप किसी भी समय भाग लेना बंद कर सकते हैं।.

कौन पात्र हो सकता है?

This study is specifically for adults who have already taken part in a study for zilucoplan, a medicine being tested for generalized myasthenia gravis. If you've been in one of those previous zilucoplan studies, you might be able to join this one.

You cannot join this study if you are currently taking part in another clinical trial where you are receiving an experimental treatment. This is to make sure that any effects seen are clearly due to zilucoplan and not another new medicine. However, you can still be in studies that are just observing health or collecting information, as long as they don't involve new medicines.

क्या यह अध्ययन आपके लिए उपयुक्त हो सकता है?

यह देखने के लिए इन त्वरित प्रश्नों का उत्तर दें कि क्या आप पात्र हो सकते हैं। यह केवल एक मार्गदर्शिका है — अंतिम निर्णय शोध टीम द्वारा लिया जाता है।.

  1. I have generalized myasthenia gravis.
  2. I have already participated in an earlier study for zilucoplan.
  3. मैं 18 वर्ष या उससे अधिक उम्र का हूँ।.
  4. I am not currently taking part in another study testing a new experimental medicine.
अपने परिणाम देखने के लिए हर प्रश्न का उत्तर दें।.

भागीदारी में क्या शामिल है?

If you decide to join this study, you will continue to receive the medicine zilucoplan. The study team will regularly check your health, how your generalized myasthenia gravis symptoms are doing, and if you have any side effects. This will involve regular visits to the study clinic, where you might have physical exams, blood tests, and answer questions about your well-being. The exact number and frequency of visits, as well as the total length of your participation, will be clearly explained by the study team. They will continue to monitor your progress over an extended period to understand the long-term effects of zilucoplan.

संभावित जोखिम और लाभ

Taking part in this study may offer potential benefits, such as continuing to receive a medicine that might help manage your generalized myasthenia gravis symptoms. You will also be closely monitored by a healthcare team. However, as with any medicine, there's always a chance of side effects, which the study team will discuss with you. Any new medicine also carries unknown risks, which is why studies like this are important. You are free to withdraw from the study at any time, for any reason, without it affecting your medical care.

स्थान (70)

  • Mg0011 41
    सत्यापित पोस्टकोड
    मोबाइल, संयुक्त राज्य अमेरिका
  • Mg0011 116
    सत्यापित पोस्टकोड
    फीनिक्स, संयुक्त राज्य अमेरिका
  • Mg0011 31
    सत्यापित पोस्टकोड
    इरविन, संयुक्त राज्य अमेरिका
  • MG0011 4
    सत्यापित पोस्टकोड
    लॉस एंजेलेस, संयुक्त राज्य अमेरिका
  • Mg0011 220
    सत्यापित पोस्टकोड
    पासाडेना, संयुक्त राज्य अमेरिका
  • Mg0011 160
    सत्यापित पोस्टकोड
    सैन फ्रांसिस्को, संयुक्त राज्य अमेरिका
  • Mg0011 24
    सत्यापित पोस्टकोड
    न्यू हेवन, संयुक्त राज्य अमेरिका
  • Mg0011 27
    सत्यापित पोस्टकोड
    वॉशिंगटन डी.सी., संयुक्त राज्य अमेरिका
  • Mg0011 25
    सत्यापित पोस्टकोड
    टाम्पा, संयुक्त राज्य अमेरिका
  • Mg0011 135
    सत्यापित पोस्टकोड
    ऑगस्टा, संयुक्त राज्य अमेरिका
  • Mg0011 188
    सत्यापित पोस्टकोड
    ग्लेनव्यू, संयुक्त राज्य अमेरिका
  • Mg0011 156
    सत्यापित पोस्टकोड
    इंडियानापोलिस, संयुक्त राज्य अमेरिका

सामान्य प्रश्न

What is 'open-label'?

Open-label means that everyone involved, including you and the study doctors, knows that you are receiving the study medicine, zilucoplan.

Who is zilucoplan for?

Zilucoplan is a medicine being studied for people who have generalized myasthenia gravis, a condition causing muscle weakness.

Can I join if I'm on another new medicine?

No, you cannot join if you are currently taking part in another study that tests an experimental treatment.

'फेज 3' अध्ययन का क्या मतलब है?

Phase 3 is usually one of the final steps in testing a new medicine, looking at its effectiveness and safety in a larger group of people before it might become widely available.

What happens after the study ends?

The study team will explain what medical care options are available to you once your participation in the study is complete.

और अधिक जानने के लिए कैसे पता करें

किसी अध्ययन में भाग लेने का निर्णय लेने से पहले हमेशा अपने जीपी या विशेषज्ञ से बात करें।.

चर्चा

समुदाय चर्चा

हमारे फोरम द्वारा संचालित community.patient.info. कृपया सम्मानजनक रहें — यह चिकित्सा सलाह नहीं है।.